TL;DR
Biohackers World sold 10,000 tickets at $500 apiece for its next event, up from 2,000 attendees in LA -- and the longevity industry backing it is projected to hit $740 billion this year.
MSM Perspective
Florida Today and the Des Moines Register covered the LA event's record attendance; Forbes and UBS have separately projected longevity as a trillion-dollar market by 2030.
X Perspective
Longevity accounts on X treat the conference growth as evidence that biohacking has completed its journey from garage subculture to consumer industry with Fortune 500 sponsors.
As this paper noted yesterday, Biohackers World drew nearly 2,000 attendees to its Los Angeles event on March 28-29 -- a record for the organization. [1] The next events, scheduled for New York in June and Chicago later in the year, are scaling dramatically: organizers have listed 10,000 tickets at approximately $500 each, reflecting a conference circuit that has outgrown boutique wellness and entered the territory of consumer expos. [2]
The market validates the ambition. The global longevity industry is projected to surpass $740 billion in 2026, according to a market report published in February. [3] UBS has separately forecast longevity spending at $8 trillion by 2030. [4] The biohacking market alone -- a subset covering wearables, supplements, and self-optimization protocols -- is valued at roughly $45 billion this year and growing at 19 percent annually. [5]
What began as a Silicon Valley subculture of self-experimenters tracking sleep scores and cycling peptides now has its own convention circuit, its own venture capital pipeline, and its own tension between evidence-based medicine and the $500-a-ticket aspiration of living forever. The conferences are where those tensions negotiate in real time.
-- NORA WHITFIELD, Chicago
Sources & X Posts
News Sources